Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Early detection and treatment of iron deficiency anemia, especially in premenopausal women, is crucial for rapid symptom improvement.

Oral finasteride, combined with drospirenone, improved hair loss in 62% of premenopausal women, with no reported side effects.

Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

FFA in young women is often missed, and no single treatment works best.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Iron supplements helped female blood donors with low iron avoid anaemia and return to donate again.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Heavier birth weight may increase the risk of early hair graying in women.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Testosterone may help increase sexual events for women with low libido due to antidepressants.